Annual Net Income
$5.96 B
+$2.67 B+81.11%
31 December 2023
Summary:
AstraZeneca annual net profit is currently $5.96 billion, with the most recent change of +$2.67 billion (+81.11%) on 31 December 2023. During the last 3 years, it has risen by +$2.76 billion (+86.33%). AZN annual net income is now -39.95% below its all-time high of $9.92 billion, reached on 31 December 2011.AZN Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
$1.43 B
-$498.00 M-25.84%
30 September 2024
Summary:
AstraZeneca quarterly net profit is currently $1.43 billion, with the most recent change of -$498.00 million (-25.84%) on 30 September 2024. Over the past year, it has increased by +$55.00 million (+4.00%). AZN quarterly net income is now -58.90% below its all-time high of $3.48 billion, reached on 30 September 2011.AZN Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
$6.50 B
+$55.00 M+0.85%
30 September 2024
Summary:
AstraZeneca TTM net profit is currently $6.50 billion, with the most recent change of +$55.00 million (+0.85%) on 30 September 2024. Over the past year, it has increased by +$599.00 million (+10.16%). AZN TTM net income is now -35.81% below its all-time high of $10.12 billion, reached on 30 September 2011.AZN TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AZN Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +81.1% | +4.0% | +10.2% |
| 3 y3 years | +86.3% | +186.5% | +341.5% |
| 5 y5 years | +176.3% | +377.9% | +215.9% |
AZN Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +5217.0% | -34.4% | +186.5% | at high | +618.4% |
| 5 y | 5 years | at high | +5217.0% | -34.4% | +186.5% | at high | +618.4% |
| alltime | all time | -40.0% | +5217.0% | -58.9% | +186.5% | -35.8% | +618.4% |
AstraZeneca Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.43 B(-25.8%) | $6.50 B(+0.9%) |
| June 2024 | - | $1.93 B(-11.6%) | $6.44 B(+1.7%) |
| Mar 2024 | - | $2.18 B(+127.0%) | $6.33 B(+6.3%) |
| Dec 2023 | $5.96 B(+81.1%) | $960.00 M(-30.1%) | $5.96 B(+1.0%) |
| Sept 2023 | - | $1.37 B(-24.4%) | $5.90 B(-4.3%) |
| June 2023 | - | $1.82 B(+0.8%) | $6.16 B(+31.0%) |
| Mar 2023 | - | $1.80 B(+100.1%) | $4.70 B(+43.1%) |
| Dec 2022 | $3.29 B(+2835.7%) | $901.00 M(-45.1%) | $3.29 B(+61.2%) |
| Sept 2022 | - | $1.64 B(+355.6%) | $2.04 B(-262.7%) |
| June 2022 | - | $360.00 M(-6.7%) | -$1.25 B(+17.9%) |
| Mar 2022 | - | $386.00 M(-211.2%) | -$1.06 B(-1049.1%) |
| Dec 2021 | $112.00 M(-96.5%) | -$347.00 M(-79.0%) | $112.00 M(-92.4%) |
| Sept 2021 | - | -$1.65 B(-400.4%) | $1.47 B(-61.0%) |
| June 2021 | - | $550.00 M(-64.8%) | $3.77 B(-5.2%) |
| Mar 2021 | - | $1.56 B(+54.2%) | $3.98 B(+24.4%) |
| Dec 2020 | $3.20 B(+139.4%) | $1.01 B(+56.2%) | $3.20 B(+28.0%) |
| Sept 2020 | - | $648.00 M(-14.3%) | $2.50 B(+16.2%) |
| June 2020 | - | $756.00 M(-3.1%) | $2.15 B(+41.1%) |
| Mar 2020 | - | $780.00 M(+149.2%) | $1.52 B(+14.0%) |
| Dec 2019 | $1.33 B(-38.1%) | $313.00 M(+4.7%) | $1.33 B(-35.1%) |
| Sept 2019 | - | $299.00 M(+130.0%) | $2.06 B(-6.0%) |
| June 2019 | - | $130.00 M(-78.1%) | $2.19 B(-9.1%) |
| Mar 2019 | - | $593.00 M(-42.6%) | $2.41 B(+11.7%) |
| Dec 2018 | $2.15 B(-28.2%) | $1.03 B(+139.9%) | $2.15 B(-11.0%) |
| Sept 2018 | - | $431.00 M(+23.1%) | $2.42 B(-9.5%) |
| June 2018 | - | $350.00 M(+2.9%) | $2.68 B(-4.5%) |
| Mar 2018 | - | $340.00 M(-73.9%) | $2.80 B(-6.6%) |
| Dec 2017 | $3.00 B(-14.2%) | $1.30 B(+89.7%) | $3.00 B(-15.3%) |
| Sept 2017 | - | $686.00 M(+43.8%) | $3.54 B(-8.5%) |
| June 2017 | - | $477.00 M(-11.2%) | $3.87 B(+14.2%) |
| Mar 2017 | - | $537.00 M(-70.8%) | $3.39 B(-3.1%) |
| Dec 2016 | $3.50 B(+23.9%) | $1.84 B(+81.7%) | $3.50 B(+41.9%) |
| Sept 2016 | - | $1.01 B(<-9900.0%) | $2.46 B(+11.0%) |
| June 2016 | - | -$3.00 M(-100.5%) | $2.22 B(-24.0%) |
| Mar 2016 | - | $646.00 M(-20.0%) | $2.92 B(+3.4%) |
| Dec 2015 | $2.83 B(+129.1%) | $808.00 M(+4.9%) | $2.83 B(+66.6%) |
| Sept 2015 | - | $770.00 M(+10.5%) | $1.70 B(+43.7%) |
| June 2015 | - | $697.00 M(+26.7%) | $1.18 B(-7.7%) |
| Mar 2015 | - | $550.00 M(-271.3%) | $1.28 B(+3.7%) |
| Dec 2014 | $1.23 B(-51.8%) | -$321.00 M(-226.4%) | $1.23 B(+19.7%) |
| Sept 2014 | - | $254.00 M(-68.1%) | $1.03 B(-49.1%) |
| June 2014 | - | $796.00 M(+57.9%) | $2.02 B(-1.3%) |
| Mar 2014 | - | $504.00 M(-196.2%) | $2.05 B(-19.8%) |
| Dec 2013 | $2.56 B(-59.0%) | -$524.00 M(-142.1%) | $2.56 B(-44.3%) |
| Sept 2013 | - | $1.25 B(+51.4%) | $4.59 B(-5.5%) |
| June 2013 | - | $823.00 M(-18.6%) | $4.85 B(-13.8%) |
| Mar 2013 | - | $1.01 B(-32.9%) | $5.63 B(-9.8%) |
| Dec 2012 | $6.24 B(-37.1%) | $1.51 B(-0.3%) | $6.24 B(+1.4%) |
| Sept 2012 | - | $1.51 B(-5.4%) | $6.15 B(-24.2%) |
| June 2012 | - | $1.60 B(-1.7%) | $8.12 B(-6.0%) |
| Mar 2012 | - | $1.63 B(+14.4%) | $8.63 B(-12.9%) |
| Dec 2011 | $9.92 B(+23.1%) | $1.42 B(-59.2%) | $9.92 B(-2.0%) |
| Sept 2011 | - | $3.48 B(+64.6%) | $10.12 B(+23.6%) |
| June 2011 | - | $2.11 B(-27.3%) | $8.19 B(+0.1%) |
| Mar 2011 | - | $2.91 B(+79.3%) | $8.18 B(+1.6%) |
| Dec 2010 | $8.05 B(+7.1%) | $1.62 B(+4.7%) | $8.05 B(+0.9%) |
| Sept 2010 | - | $1.55 B(-26.5%) | $7.99 B(-6.6%) |
| June 2010 | - | $2.11 B(-24.1%) | $8.55 B(+4.9%) |
| Mar 2010 | - | $2.78 B(+78.8%) | $8.15 B(+8.4%) |
| Dec 2009 | $7.52 B(+23.3%) | $1.55 B(-26.6%) | $7.52 B(+4.2%) |
| Sept 2009 | - | $2.12 B(+23.9%) | $7.22 B(+5.6%) |
| June 2009 | - | $1.71 B(-20.5%) | $6.83 B(+1.3%) |
| Mar 2009 | - | $2.15 B(+72.0%) | $6.74 B(+10.5%) |
| Dec 2008 | $6.10 B | $1.25 B(-27.9%) | $6.10 B(-0.3%) |
| Sept 2008 | - | $1.73 B(+6.8%) | $6.12 B(+6.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2008 | - | $1.62 B(+7.8%) | $5.73 B(+3.5%) |
| Mar 2008 | - | $1.50 B(+18.7%) | $5.54 B(-1.0%) |
| Dec 2007 | $5.59 B(-7.4%) | $1.27 B(-5.7%) | $5.59 B(-2.9%) |
| Sept 2007 | - | $1.34 B(-5.8%) | $5.76 B(-4.1%) |
| June 2007 | - | $1.43 B(-8.6%) | $6.00 B(-2.8%) |
| Mar 2007 | - | $1.56 B(+8.9%) | $6.18 B(+2.3%) |
| Dec 2006 | $6.04 B(+28.4%) | $1.43 B(-9.8%) | $6.04 B(+3.6%) |
| Sept 2006 | - | $1.59 B(-0.8%) | $5.83 B(+6.7%) |
| June 2006 | - | $1.60 B(+12.4%) | $5.47 B(+7.5%) |
| Mar 2006 | - | $1.42 B(+16.3%) | $5.09 B(+8.2%) |
| Dec 2005 | $4.71 B(+28.4%) | $1.22 B(+0.1%) | $4.71 B(+6.8%) |
| Sept 2005 | - | $1.22 B(+0.3%) | $4.41 B(+2.1%) |
| June 2005 | - | $1.22 B(+17.2%) | $4.32 B(+10.4%) |
| Mar 2005 | - | $1.04 B(+12.7%) | $3.91 B(+6.6%) |
| Dec 2004 | $3.66 B(+21.2%) | $923.00 M(-18.5%) | $3.66 B(+9.0%) |
| Sept 2004 | - | $1.13 B(+39.7%) | $3.36 B(+11.0%) |
| June 2004 | - | $811.00 M(+1.8%) | $3.03 B(+4.9%) |
| Mar 2004 | - | $797.00 M(+28.3%) | $2.89 B(-4.5%) |
| Dec 2003 | $3.02 B(+6.6%) | $621.00 M(-22.2%) | $3.02 B(+6.6%) |
| Sept 2003 | - | $798.55 M(+19.4%) | $2.83 B(+4.8%) |
| June 2003 | - | $668.92 M(-28.3%) | $2.71 B(-3.8%) |
| Mar 2003 | - | $933.54 M(+115.5%) | $2.81 B(-0.9%) |
| Dec 2002 | $2.84 B(-4.4%) | $433.29 M(-35.3%) | $2.84 B(-11.1%) |
| Sept 2002 | - | $669.71 M(-13.6%) | $3.19 B(-1.3%) |
| June 2002 | - | $775.00 M(-19.1%) | $3.23 B(+2.8%) |
| Mar 2002 | - | $958.00 M(+21.7%) | $3.14 B(+6.0%) |
| Dec 2001 | $2.97 B(+16.8%) | $787.00 M(+10.7%) | $2.96 B(+8.7%) |
| Sept 2001 | - | $711.00 M(+3.6%) | $2.73 B(+2.2%) |
| June 2001 | - | $686.00 M(-12.1%) | $2.67 B(+0.3%) |
| Mar 2001 | - | $780.46 M(+42.1%) | $2.66 B(+4.7%) |
| Dec 2000 | $2.54 B(+122.3%) | $549.27 M(-15.6%) | $2.54 B(+39.7%) |
| Sept 2000 | - | $651.18 M(-4.1%) | $1.82 B(+10.1%) |
| June 2000 | - | $679.03 M(+2.7%) | $1.65 B(+18.9%) |
| Mar 2000 | - | $661.15 M(-482.2%) | $1.39 B(+21.4%) |
| Dec 1999 | $1.14 B(-56.2%) | -$173.00 M(-135.7%) | $1.14 B(-61.2%) |
| Sept 1999 | - | $484.00 M(+16.3%) | $2.95 B(+9.3%) |
| June 1999 | - | $416.00 M(0.0%) | $2.70 B(-10.1%) |
| Mar 1999 | - | $416.00 M(-74.5%) | $3.00 B(+1.7%) |
| Dec 1998 | $2.61 B(+116.4%) | $1.63 B(+598.7%) | $2.95 B(+79.8%) |
| Sept 1998 | - | $233.40 M(-67.6%) | $1.64 B(-3.6%) |
| June 1998 | - | $720.00 M(+96.7%) | $1.70 B(+25.6%) |
| Mar 1998 | - | $366.00 M(+13.8%) | $1.36 B(-0.5%) |
| Dec 1997 | $1.21 B(+9.6%) | $321.57 M(+9.0%) | $1.36 B(-18.5%) |
| Sept 1997 | - | $295.10 M(-20.8%) | $1.67 B(+3.7%) |
| June 1997 | - | $372.50 M(0.0%) | $1.61 B(+3.7%) |
| Mar 1997 | - | $372.50 M(-40.9%) | $1.55 B(+3.8%) |
| Dec 1996 | $1.10 B(+112.1%) | $630.04 M(+167.4%) | $1.50 B(+51.6%) |
| Sept 1996 | - | $235.60 M(-25.2%) | $986.59 M(+11.6%) |
| June 1996 | - | $315.00 M(0.0%) | $883.69 M(+5.4%) |
| Mar 1996 | - | $315.00 M(+160.3%) | $838.19 M(+5.8%) |
| Dec 1995 | $519.19 M(-25.0%) | $120.99 M(-8.8%) | $792.59 M(-20.6%) |
| Sept 1995 | - | $132.70 M(-50.8%) | $998.69 M(-3.9%) |
| June 1995 | - | $269.50 M(+0.0%) | $1.04 B(-7.0%) |
| Mar 1995 | - | $269.40 M(-17.6%) | $1.12 B(+7.3%) |
| Dec 1994 | $692.59 M(+8.6%) | $327.09 M(+88.7%) | $1.04 B(+24.4%) |
| Sept 1994 | - | $173.30 M(-50.2%) | $837.64 M(+4.7%) |
| June 1994 | - | $348.10 M(+79.7%) | $800.34 M(+24.7%) |
| Mar 1994 | - | $193.70 M(+58.1%) | $641.74 M(+0.7%) |
| Dec 1993 | $637.54 M(+425.4%) | $122.54 M(-9.9%) | $637.54 M(+23.8%) |
| Sept 1993 | - | $136.00 M(-28.2%) | $515.00 M(+35.9%) |
| June 1993 | - | $189.50 M(0.0%) | $379.00 M(+100.0%) |
| Mar 1993 | - | $189.50 M | $189.50 M |
| Dec 1992 | $121.34 M(-81.2%) | - | - |
| Dec 1991 | $645.56 M(+50.8%) | - | - |
| Dec 1990 | $428.22 M | - | - |
FAQ
- What is AstraZeneca annual net profit?
- What is the all time high annual net income for AstraZeneca?
- What is AstraZeneca annual net income year-on-year change?
- What is AstraZeneca quarterly net profit?
- What is the all time high quarterly net income for AstraZeneca?
- What is AstraZeneca quarterly net income year-on-year change?
- What is AstraZeneca TTM net profit?
- What is the all time high TTM net income for AstraZeneca?
- What is AstraZeneca TTM net income year-on-year change?
What is AstraZeneca annual net profit?
The current annual net income of AZN is $5.96 B
What is the all time high annual net income for AstraZeneca?
AstraZeneca all-time high annual net profit is $9.92 B
What is AstraZeneca annual net income year-on-year change?
Over the past year, AZN annual net profit has changed by +$2.67 B (+81.11%)
What is AstraZeneca quarterly net profit?
The current quarterly net income of AZN is $1.43 B
What is the all time high quarterly net income for AstraZeneca?
AstraZeneca all-time high quarterly net profit is $3.48 B
What is AstraZeneca quarterly net income year-on-year change?
Over the past year, AZN quarterly net profit has changed by +$55.00 M (+4.00%)
What is AstraZeneca TTM net profit?
The current TTM net income of AZN is $6.50 B
What is the all time high TTM net income for AstraZeneca?
AstraZeneca all-time high TTM net profit is $10.12 B
What is AstraZeneca TTM net income year-on-year change?
Over the past year, AZN TTM net profit has changed by +$599.00 M (+10.16%)